Sanofi India Ltd. - Research Center
500674 SANOFI Group (A) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Dec ' 23 | Dec ' 22 | Dec ' 21 | Dec ' 20 | Dec ' 19 | |
|---|---|---|---|---|---|
| Sales | 2,851.10 | 2,770.10 | 2,956.60 | 2,901.90 | 3,070.60 |
| Operating profit | 804.00 | 704.40 | 762.50 | 713.10 | 665.30 |
| Interest | 1.70 | 1.70 | 1.80 | 1.80 | 0.30 |
| Gross profit | 867.60 | 774.20 | 835.10 | 801.10 | 759.10 |
| EPS (Rs) | 262.26 | 269.83 | 410.61 | 207.65 | 180.09 |
Annual
results in details
| Dec ' 23 | Dec ' 22 | Dec ' 21 | Dec ' 20 | Dec ' 19 | |
|---|---|---|---|---|---|
| Other income | 65.30 | 71.50 | 74.40 | 89.80 | 94.10 |
| Stock adjustment | -292.40 | -11.10 | 43.10 | 57.50 | 2.30 |
| Raw material | 564.40 | 549.70 | 555.10 | 591.40 | 863.60 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 370.60 | 405.90 | 433.90 | 460.80 | 449.70 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 1,404.50 | 1,121.20 | 1,162.00 | 1,079.10 | 1,089.70 |
| Provisions made | - | - | - | - | - |
| Depreciation | 39.60 | 41.90 | 66.70 | 82.20 | 99.90 |
| Taxation | 242.60 | 243.70 | 313.20 | 199.60 | 185.70 |
| Net profit / loss | 603.20 | 620.60 | 944.40 | 477.60 | 414.20 |
| Extra ordinary item | 17.80 | 132.00 | 489.20 | -41.70 | -59.30 |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 28.20 | 25.43 | 25.79 | 24.57 | 21.67 |
| GPM (%) | 29.75 | 27.25 | 27.55 | 26.78 | 23.99 |
| NPM (%) | 20.68 | 21.84 | 31.16 | 15.96 | 13.09 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis